What is Injective?
Founded in 2018 and headquartered in New York, NY, Injective is a prominent smart contracts platform provider. Its core focus lies in developing and supporting decentralized finance (DeFi) applications, aiming to foster a more open and accessible financial ecosystem. The company's technological advancements and strategic positioning within the burgeoning DeFi sector have attracted significant backing from prominent venture capital firms and crypto-focused investment funds.
How much funding has Injective raised?
Injective has raised a total of $190M across 2 funding rounds:
Series C
$40M
Series D
$150M
Series C (2022): $40M with participation from Jump Crypto
Series D (2023): $150M led by Pantera Capital and Kraken Ventures
Key Investors in Injective
Pantera Capital
Pantera Capital is a blockchain-focused investment firm that backs founders and digital asset networks, combining venture and hedge strategies to give investors broad exposure to cryptocurrencies, token projects and companies shaping future financial infrastructure.
Kraken Ventures
Kraken Ventures is an independent investment fund targeting early stage companies and protocols across the crypto and fintech ecosystem. The fund invests in the technologies powering the next wave of crypto and fintech innovation, providing entrepreneurs with the resources and industry expertise they need to build and scale their business.
Jump Crypto
Undisclosed investor participating in the funding round.
What's next for Injective?
With the recent influx of capital, Injective is poised for accelerated growth and further development of its decentralized finance infrastructure. The strategic nature of the latest investment suggests a focus on expanding market reach, enhancing platform capabilities, and potentially forging new partnerships within the blockchain and fintech industries. This infusion of resources will likely enable Injective to solidify its position as a leader in the DeFi space and drive innovation in smart contract applications.
See full Injective company page
